MoneyWorks4Me

Marksans Pharma's arm gets UK MHRA grant for market authorisation of Loperamide Capsules

09 Dec 2021 Evaluate

UK MHRA has granted market authorisation to Marksans Pharma's wholly owned subsidiary Relonchem for Loperamide 2mg Hard Capsules. Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..